Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11872289 Anti-MUC1 antibody-drug conjugate

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Anke Flechner0

Antje Danielczyk0

Akiko Nagase0

Johanna Gellert0

Doreen Weigelt0

Date of Patent

January 16, 2024

0

Patent Application Number

178786110

Date Filed

August 1, 2022

0

Patent Citations

US Patent 7837980 Partially loaded antibodies and methods of their conjugation

0

US Patent 9359439 Fab-glycosylated antibodies

0

US Patent 9494587 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates

0

US Patent 9505848 Engineered heterodimeric protein domains

0

US Patent 9732160 Methods of treating acute myeloid leukemia with antibodies to bone marrow stromal antigen 1

0

US Patent 9808537 Antibody-drug conjugate

0

US Patent 9845361 Recognition molecules for the treatment and detection of tumors

0

US Patent 9850312 Anti-TROP2 antibody-drug conjugate

0

...

Patent Primary Examiner

Aurora M Fontainhas

0

CPC Code

0

0

0

0

0

Patent abstract

The present invention pertains to novel antibody drug conjugates (ADC) comprising anti-MUC1 antibody. In particular, said ADC showed significant anti-tumor efficacy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11872289 Anti-MUC1 antibody-drug conjugate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool